Select a page
  • Home
  • Our Team
  • Blogs
  • About IBR
    • The Magazine
    • Sponsor
  • Archive
    • Past Issues
    • Article & Blog Database
  • Join IBR
  • Home
  • Our Team
  • Blogs
  • About IBR
    • The Magazine
    • Sponsor
  • Archive
    • Past Issues
    • Article & Blog Database
  • Join IBR

Spring 2010

The Big Pharma Bust

The collapse of Western pharmaceutical companies is inevitable
April 3, 2010 | Juthika Thakur

TAGS
Asia Biocon China Cipla Corporate Strategy Dr. Reddy's Laboratories Eli Lilly GlaxoSmithKline Healthcare and Pharmaceuticals India Juthika Thakur Merck Natasha Neal Novartis Pfizer Pharmaceuticals Piramal Enterprises Published Sanofi-Aventis Spring 2010 Volume 1
CONTACT THE AUTHOR
Juthika Thakur
COMMENTS

Most Read Articles
Shopify: Simplifying the Future of Retail
by Alex Du
Interview: Dean Connor, Sun Life Financial
by Ivey Business Review
Lego: Restructuring, Brick By Brick
by Jerry Wang and Eden Ip
Calm: The Calm Before the Storm
by Virginia Ling and Stephanie Li
GoPro: Capturing a New Audience
by Gary Wu and Jackie Wang
Related Articles
The Perfect Remedy
by David Stewart and Sabriya Karim
The Biosimilar Onslaught
by Kevin Shi and Nawid Sayed
Teva: Don’t Be so Generic
by Sooruj Ghangass and Gordon Sun
Pfizer: Betting on Success
by Ethan Milne
The Battle Over Your Genes
by Lauren Lee
Gilead: Cultivating the Pipeline
by Jason Cheung and Dennis Zhan
About IBR

Ivey Business Review is written, designed, and managed by undergraduate students at the Ivey Business School and is the only publication of its kind in the country. IBR publishes two issues annually in December and April with content created exclusively by students and maintains an active blog, curated by the IBR Editorial Board, with contributions from students and young alumni.

IBR On Twitter
  • We are proud to announce the release of our Spring 2018 issue (https://t.co/rFKOrVi1kL ). Find articles proposing B… https://t.co/VaHpa9wO5n
  • We are proud to announce the release of our Fall 2017 edition, with articles such as a biosimilar strategy for Teva… https://t.co/khESwrfGmU
  • Our feature interview, @mhyattbluecat sold his company for $400M! Find out his thoughts on entrepreneurship here: https://t.co/PL7oqL7BcG
About Ivey

The Ivey Business School at Western University offers undergraduate (HBA) and graduate degree programs (MSc, MBA, Executive MBA and PhD) in addition to non-degree Executive Development programs.

Copyright ® 2020, Ivey Business School | Terms of Use & Privacy Policy